Grants.gov · FDA · Cooperative Agreement
Use of Digital Health Technologies in Clinical Investigations to Support Drug and Biological Product Development (U01) Clinical Trials Optional
Food and Drug Administration
- Status
- Open
- Maximum funding
- $1.1M
- Deadline
- Aug 20, 2026
- Instrument
- Cooperative Agreement
About this funding opportunity
The purpose of this Notice of Funding Opportunity (NOFO) is to address topics related to the use of digital health technologies (DHTs) for remote data acquisition in clinical investigations to support drug development.
Topic areas: Agriculture and Food, Public Policy and Governance, Life Sciences and Health.
Funding amount
This cooperative agreement provides Up to $1.1M in funding, up to $1.1M per award.
Deadline
Applications are due Aug 20, 2026. Confirm the exact closing time on the official program page before applying.
Who can apply
This opportunity is open to the following applicant types:
- NGOs
- Public Authorities
- SME
- University
- Large Company
Eligibility
The program did not publish a separate eligibility statement. See the official opportunity page for the full eligibility criteria.
Agency
Use of Digital Health Technologies in Clinical Investigations to Support Drug and Biological Product Development (U01) Clinical Trials Optional is administered by Food and Drug Administration (FDA), listed via Grants.gov.
Open the official opportunity page Browse all US R&D funding on GrantField
Programme data is aggregated by GrantField from public sources and may change. Always verify details on the official page before applying.